Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fuhr

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1990
Electrocutaneous reflexes and multimodality evoked potentials in multiple sclerosisW G Friedli, P Fuhr
Social Science & Medicine (1982)|January 1, 1983
Competition's flawed perspective on the health care market and an alternative approachB J Reilly, J P Fuhr
American Health & Drug Benefits|April 12, 2016
The Economics of Medicare Accountable Care OrganizationsErwin A Blackstone, Joseph P Fuhr
Journal of Health Care Finance|November 1, 2008
Specialty hospitals: the economics and policy issues they poseErwin A Blackstone, Joseph P Fuhr
Praxis|May 2, 2003
[Inclusion body myositis (IBM) -- a review]A Czaplinski, S Renaud, P Fuhr
Journal of Health Politics, Policy and Law|January 1, 1989
Hospital mergers and antitrust: an economic analysisE A Blackstone, J P Fuhr
Hospital & Health Services Administration|December 12, 1982
Private and public health insurance: competition incentives for the control of health care costsB J Reilly, J P Fuhr
Schweizerische Medizinische Wochenschrift|November 4, 2000
[Late manifestation of radiation injury to the plexus brachialis and plexus lumbosacralis]M Strub, P Fuhr, L Kappos
Electroencephalography and Clinical Neurophysiology|August 1, 1991
Spinal motor neuron excitability during the silent period after cortical stimulationP Fuhr, R Agostino, M Hallett
Biotechnology Healthcare|May 19, 2012
Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safetyErwin A Blackstone, Joseph P Fuhr
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1990
Electrocutaneous reflexes and multimodality evoked potentials in multiple sclerosisW G Friedli, P Fuhr
Social Science & Medicine (1982)|January 1, 1983
Competition's flawed perspective on the health care market and an alternative approachB J Reilly, J P Fuhr
American Health & Drug Benefits|April 12, 2016
The Economics of Medicare Accountable Care OrganizationsErwin A Blackstone, Joseph P Fuhr
Journal of Health Care Finance|November 1, 2008
Specialty hospitals: the economics and policy issues they poseErwin A Blackstone, Joseph P Fuhr
Praxis|May 2, 2003
[Inclusion body myositis (IBM) -- a review]A Czaplinski, S Renaud, P Fuhr
Journal of Health Politics, Policy and Law|January 1, 1989
Hospital mergers and antitrust: an economic analysisE A Blackstone, J P Fuhr
Hospital & Health Services Administration|December 12, 1982
Private and public health insurance: competition incentives for the control of health care costsB J Reilly, J P Fuhr
Schweizerische Medizinische Wochenschrift|November 4, 2000
[Late manifestation of radiation injury to the plexus brachialis and plexus lumbosacralis]M Strub, P Fuhr, L Kappos
Electroencephalography and Clinical Neurophysiology|August 1, 1991
Spinal motor neuron excitability during the silent period after cortical stimulationP Fuhr, R Agostino, M Hallett
Biotechnology Healthcare|May 19, 2012
Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safetyErwin A Blackstone, Joseph P Fuhr
Pageof 11